WuXi PharmaTech (Cayman) Inc. Accounts Receivable
WuXi PharmaTech (Cayman) Inc. had Accounts Receivable of $162.94 million as of 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2015-04-15
- 2014-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $162.94M.
- 2013-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $127.00M.
- 2012-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $99.58M.
- 2011-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $72.74M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2014-12-31 | $162.94M 20-F · filed 2015-04-15 |
| 2013-12-31 | $127.00M 20-F · filed 2015-04-15 |
| 2012-12-31 | $99.58M 20-F · filed 2014-04-15 |
| 2011-12-31 | $72.74M 20-F · filed 2013-04-17 |
| 2010-12-31 | $57.04M 20-F · filed 2012-04-20 |
| 2009-12-31 | $45.82M 20-F · filed 2011-04-27 |